Search results
Found 12050 matches for
New research led by Oxford BHF CRE Intermediate Transition Fellow Dr Kerstin Timm shows that a recently developed imaging technique pioneered by the Tyler Group can detect early metabolic changes in the heart caused by a commonly used chemotherapy drug, which is known to increase risk of heart failure in cancer survivors.
Neuroscience
We host a number of internationally recognised neuroscience groups, with expertise in a wide range of experimental and computational methods.
Metabolism & Endocrinology
We use the full range of modern molecular genetic and imaging techniques to study a range of metabolic areas.
Functional Genomics
We play a leading role in the development of more efficient and cost-effective sequencing technologies.
Development & Cell Biology
We dissect the molecular and cellular mechanisms underlying a range of developmental and reproductive processes.
Cell Physiology
We study everything from the structure of ion channels and transporters right up to their role in behaviour and human disease.
Cardiac Sciences
We are recognised internationally for our pioneering approaches to systems biology and to computational modelling of the heart.